Dr. Laura Valle has dedicated her scientific career to the identification of the genetic causes of cancer predisposition and the better characterization of new hereditary cancer syndromes, which has led to her consolidation as world expert in the subject. In this field, her most relevant contributions have been the description of FAN1 in 2015 and BRF1 in 2017 as genes potentially responsible for hereditary colon cancer, both findings published in the prestigious scientific journal Gastroenterology (impact factor (IF): 18.3); the identification of the TGBRII allele-specific expression as a possible predisposing factor to colorectal cancer, resulting in a publication in Science (IF: 37.2) and in a patent; and the molecular and clinical characterization of several hereditary cancer syndromes, which has resulted in numerous publications in journals such as the Journal of Clinical Oncology (IF: 24), Gut (IF: 16.6) or Genetics in Medicine (IF: 8.2), and which has had a very relevant impact in the translation into genetic diagnosis and counseling in cancer. Laura Valle obtained Bachelor degrees in Biology (2000, Award to the most outstanding graduate student) and in Biochemistry (2001, Spanish National Award to outstanding University graduate student) at the University of Navarra. She carried out her Ph.D. thesis about hereditary colon cancer at the Spanish Cancer Research Center (CNIO) under the supervision of Dr. Miguel Urioste (2006, Extraordinary Doctorate Award), which resulted in 12 publications, 7 as first author. In order to continue her work on genetic susceptibility to cancer, Laura did a postdoctoral stay (2006-2008) in the laboratory of Dr. Albert de la Chapelle at the Ohio State University Comprehensive Cancer Center, which resulted in a publication in Science, two in Cancer Research and in one patent. In January 2009, Laura Valle joined the Hereditary Cancer Program of the Institut Català d'Oncologia (IDIBELL), led by Dr. Gabriel Capellá, to develop a research line in hereditary colon cancer. As Principal Investigator (2009-2017) and despite her two maternities (2010 and 2011), she has led 20 scientific articles and reviews (corresponding author) and has secured continued funding from the Spanish Ministry of Economy and Competitiveness (BFU2009-10281; SAF2012-38885; SAF2016-80888, total funding: 540,500€ and two contracts "Training of Research Personnel (FPI)"), a L'Oréal-UNESCO "for women in science" research award, a Ramón y Cajal contract (2010-2015), and funding from the I3 program for the stabilization of doctors (2017-2019). In 2012 she obtained the accreditation in Human Genetics and the National Award to the most outstanding young researcher in Human Genetics, both awarded by the Spanish Association of Human Genetics. In 2015 she received the second prize of the RTICC award on cooperative research in oncology for the identification of FAN1 as a hereditary colon cancer gene. That same year she received several social awards in recognition of her excellent scientific work and professional career. CAREER BREAKS. Two maternities. Dates of birth: 04/03/2010; 21/06/2011 SCIENTIFIC PRODUCTION (2003-2018) [Source: Web of Science May 2018; JCR, IF of the year of publication] H-index: 14 # Publications (research articles/letters and reviews): 38 (+ 1 in press) Total citation number: 875 Average # of citations / article: 25.74 (34 articles with citation data in WOS)*First author: 9 articles (Mean IF: 9.53; Q1, n=6; D1, n=4) *Last author: 15 articles (Mean IF: 8.65; Q1, n=15; D1, n=7) *Corresponding author: 23 articles (Mean IF: 8.15; Q1, n=20; D1, n=10) [*Reviews excluded. Reviews (sole author): 3 (mean IF: 4.88)]